CN1086298C - Ointment for rheumatic spur - Google Patents

Ointment for rheumatic spur Download PDF

Info

Publication number
CN1086298C
CN1086298C CN99116404A CN99116404A CN1086298C CN 1086298 C CN1086298 C CN 1086298C CN 99116404 A CN99116404 A CN 99116404A CN 99116404 A CN99116404 A CN 99116404A CN 1086298 C CN1086298 C CN 1086298C
Authority
CN
China
Prior art keywords
radix
herba
rhizoma
root
spurs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN99116404A
Other languages
Chinese (zh)
Other versions
CN1231203A (en
Inventor
徐风
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN99116404A priority Critical patent/CN1086298C/en
Publication of CN1231203A publication Critical patent/CN1231203A/en
Application granted granted Critical
Publication of CN1086298C publication Critical patent/CN1086298C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to an ointment for rheumatic spurs, which uses Chinese angelica root-tip, safflower, peach kernel, rhizome of Sichuan lovage, milletol stem, RuMo, panax notoginseng, fox glove, herba cistanch, psoralea fruit, deglued antler powder, keel, rhizome of drynaria, epimedium, cibot rhizome, eucommia bark, blood notoginseng, cistanche stem, psoralea seed, cohosh root, money root, atractylodes rhizome, dahurian angelica root, asarum herb, beautiful millettia root, philippine flemingia root, notopterygium root, pubescent angelica root, radix aconiti, wild aconite, slteeophaga plancyi, centipede and Chinese ephedra as raw materials; the raw materials are refined to paste according to the traditional methods, then the paste is spread on hard paper, and the ointment for rheumatic spurs can be obtained. The ointment for rheumatic spurs is used for treating rheumatism and spurs; the ointment for rheumatic spurs is pasted at ill parts so that medicines are directly impregnated into periosteum and bone focus parts through skin, mucosae, muscular layers and capillaries; and thereby, the effects that the spurs are gradually shrunk and softened are realized. The present invention has the advantages of favorable curative effect and no recurrence after cure.

Description

Ointment for rheumatic spur
The present invention relates to the external application medicine with the Chinese medicine preparation of medicine.
Cervical spondylosis, lumbar spondylosis, prolapse of lumbar intervertebral disc, sciatica, knee hyperplasia, each position hyperosteogeny is commonly called as bony spur.Be the common frdquently encountered disease of middle-aged and elderly people, especially more general in personnel's morbidity of office work, it is the difficult pertinacious disease in orthopaedics field.Its main clinical manifestation is that acid is expanded, numbness, pain, limb function are limited, if mistake is controlled or delay treatment, the lighter causes disorder of limb ' s activity, and weight person causes paralysis, and people's physical and mental health is caused very big misery.
At present, treating above-mentioned disease does not all have good method or medicine, and prior treatment method mainly is physiotherapys such as traction, acupuncture-moxibustion, physical therapy, massage, massage, though can become flexible muscles and bones, the pain of releiving can not get radical cure, and often touching difficulty more.
The existing medicine that uses mainly is " Musk Analgesic Plaster ", " SUANTONG LING ", " bony spur liquid ", " pain-relieving liquid ", " KANGGU ZENGSHENG WAN " etc., all is to be main target with the eliminate pain, and the course of treatment is long, general 50 days is a course of treatment, and 3 to 5 courses of treatment are produce effects, and only effective to light disease.And oral drugs are transported to focus portion again through the blood circulation liver detoxification, and its active ingredient remains little, and effect lowers, and bigger to gastric irritation, and the curative effect instability can only be taken stopgap measures, and can not effect a permanent cure.
Purpose of the present invention is to provide a kind of with the Chinese medicine preparation, in the mode of externally applied plaster, the treatment rheumatism, the ointment for rheumatic spur of hyperosteogeny neck, shoulder, lumbar spondylosis makes medicine pass through skin, mucosa, flesh layer, blood capillary, directly be penetrated into periosteum, sclerotin focus portion, strong osmotic, blood vessel dilating improves blood capillary in focal zone microcirculation, the expansion bone, Haversian canal, strengthen the bone intracellular metabolic, reach and improve nutriture in the skeleton, and reach the purpose of treatment rheumatism involving the bone.
The present invention realizes its purpose by following prescription.
1. component and content: (consumption is %)
Radix Angelicae Sinensis 0.9-4.9% Flos Carthami 0.9-1.7% Semen Persicae 0.9-1.7%
Rhizoma Chuanxiong 0.9-1.7% Caulis seu Radix Schisandrae Henryi 0.9-1.7% breast does not have 0.9-5.2%
Radix Notoginseng 0.9-5.2% Radix Rehmanniae Preparata 2.6-5.2% Herba Cistanches 2.6-5.2%
Fructus Psoraleae 2.6-5.2% Cornu Cervi Degelatinatum 2.6-5.2% Os Draconis 2.6-5.2%
Rhizoma Drynariae 2.6-5.2% Herba Epimedii 1.7-3.5% Rhizoma Cibotii 1.7-5.2%
Cortex Eucommiae 1.7-5.2% XUESANQI 1.7-5.2% tap seven 1.7-5.2%
Kowtow sub seven 1.7-5.2% Radix Caulophylli 1.7-5.2% Herba Parnassiae Wightianae 1.7-2%
Rhizoma Atractylodis 1.7-5.2% Radix Angelicae Dahuricae 1.7-3.5% Herba Asari 1.7-3.5%
Millettia Speciosa 1.7-5.2% Radix Flemingiae Philippinensis 1.7-5.2% Rhizoma Et Radix Notopterygii 1.7-5.2%
Radix Angelicae Pubescentis 1.7-5.2% Radix Aconiti 1.7-5.2% Radix Aconiti Kusnezoffii 1.7-5.2%
Eupolyphoge sinensis 1.7-3.5% Scolopendra 1.7-3.5% Herba Ephedrae 1.7-5.2%
The formula optimization weight proportion scope of preparation medicine of the present invention is:
Radix Angelicae Sinensis 1-4% Flos Carthami 1-1.5% Semen Persicae 1-1.5%
Rhizoma Chuanxiong 1-1.5% Caulis seu Radix Schisandrae Henryi 1-1.5% breast does not have 1-5%
Radix Notoginseng 1-5% Radix Rehmanniae Preparata 3-5% Herba Cistanches 3-5%
Fructus Psoraleae 3-5% Cornu Cervi Degelatinatum 3-5% Os Draconis 3-5%
Rhizoma Drynariae 3-5% Herba Epimedii 2-3% Rhizoma Cibotii 2-5%
Cortex Eucommiae 2-5% XUESANQI 2-5% tap seven 2-5%
Kowtow sub seven 2-5% Radix Caulophylli 2-5% Herba Parnassiae Wightianae 1.7-2%
Rhizoma Atractylodis 2-5% Radix Angelicae Dahuricae 2-3% Herba Asari 2-3%
Millettia Speciosa 2-5% Radix Flemingiae Philippinensis 2-5% Rhizoma Et Radix Notopterygii 2-5%
Radix Angelicae Pubescentis 2-5% Radix Aconiti 2-5% Radix Aconiti Kusnezoffii 2-5%
Eupolyphoge sinensis 2-3% Scolopendra 2-3% Herba Ephedrae 2-5%
2. method for production
By traditional method, refine into cream, spread out on cardboard, topped thereon layer of transparent plastic sheeting is goods.
3. storage
The airtight shady and cool drying place that is positioned over, room temperature is preserved, and storage life is half a year.
4. usage and consumption
Thin film is opened, be applied to and wash the affected part of wiping away drying, whenever put up replacing on the three.One month is a course of treatment, and light disease person uses a course of treatment, three recoveries from illness course of treatment of serious symptom person.
The pharmacological mechanism of above-mentioned prescription:
Motherland's medical science is thought, the formation of hyperosteogeny, bony spur is that the human body sclerotin is aging, the result of regression, osteocyte multiple fission.The somebody thinks that hyperosteogeny and wind-cold damp pathogen have no relation, and the medicine of being developed is target with the pain relieving only, and does not have the meaning of wind dispelling expelling cold and dampness.Actually this is not so, and the invasion and attack of wind-cold damp pathogen are to cause hyperosteogeny, the key factor that bony spur forms." institute of heresy gathers, and its gas must be empty ", " wind-cold damp pathogen, three gas are assorted to be numbness to closing ", when human righteousness's deficiency, the wind-cold damp pathogen of impression is then taken advantage of a weak point, and invades fur muscles and bones, attacks into the meridians blood vessels, wound strain in addition, sclerotin is aging, makes B﹠J disease, cervical and lumbar diseases give birth to one after another.
Wind-cold damp pathogen is invaded the meridians blood vessels, goes for a long time and not, and numbness resistance meridians, stasis of blood plug is obstructed, stagnation of QI and blood may bring about pain, all pains are done.Wind-cold damp pathogen is invaded cervical region, then can cause cervical spondylosis, invades shoulder and then causes scapulohumeral periarthritis, invades waist and then can cause lumbago and skelalgia." General Treatise on the Cause and Symptoms of Diseases " " kidney master waist foot, kidney channel is deficient, air-cooledly takes advantage of it, so lumbago also ".The waist is a house of the kidney, kidney governing bones, living marrow, the then bone marrow scarcity of suffering from a deficiency of the kidney, skeleton loses supports, and then sclerotin is aging, and degeneration forms rheumatism involving the bone." strain in kidney, moving injury of meridian is invaded by cold wind again, and vim and vigour are hit and fought, so lumbago also ".Lumbago, hyperosteogeny are described, deficient with kidney channel, the wind-cold damp pathogen invasion and attack have substantial connection.So in treatment, when selecting anti-bone regeneration medicine for use, also use the medicine of a little wind-expelling and dispelling dampnesses, cold expelling, activating blood circulation and dissipating blood stasis, reducing swelling and alleviating pain, than use resisting hyperosteogeny medicine merely, curative effect improves greatly like this.
Advantage of the present invention is: from the etiology and pathology of hyperosteogeny, the side of executing selects medicine, both wind dispelling, cold expelling, damp eliminatings, the kidney invigorating again, replenishing essence, beneficial marrow, promoting blood circulation and detumescence pain relieving.Both eliminate, controlled the caused pain of hypertrophy bone, and can stop bony spur to form to resisting hyperosteogeny again.It is fast to be affixed on the affected part post-absorption, does not have allergy, and effect is lasting, has no side effect.Use by the course of treatment, can make bony spur reach atrophy, softening, the effect for the treatment of both the principal and secondary aspects of a disease gradually.
Model case:
Case one: it is surplus that Indonesia patient, Mr. Lian Yingxin suffer from cervical spondylosis 10 years, and neck is stiff to coagulate, limitation of activity, headache and dizzy, vexed insomnia, the acid of neck shoulder soft tissue is expanded and is felt bad, and right upper extremity is numb to expand, and once seeks medical advice in American-European, Japan, Singapore, the doctor advises its operation, and the patient fears operation, through the external application ointment for rheumatic spur, cervical vertebra bony spur for oral administration is loose, and a week promptly takes an evident turn for the better, two courses of treatment, neck-shoulder pain is eliminated, and the band medicine goes home to consolidate curative effect.
Case two: Longhua, Shenzhen patient, Mr. Wang Yiyu, prolapse of lumbar intervertebral disc 7 years, pain is unbearably, can not take care of oneself, the doctor advises its operation, and through the external application ointment for rheumatic spur, the prominent retraction of waist for oral administration is red, one all lumbago and skelalgia subtract greatly, and be cured three courses of treatment, and lumbago and skelalgia is from removing though operate on.
Provide two embodiment below in conjunction with the present invention:
Embodiment 1:
Radix Angelicae Sinensis 4% Flos Carthami 1.5% Semen Persicae 1.5% Rhizoma Chuanxiong 1.5%
Caulis seu Radix Schisandrae Henryi 1.5% breast does not have 2% Radix Notoginseng, 1.5% Radix Rehmanniae Preparata 4%
Herba Cistanches 4% Fructus Psoraleae 3% Cornu Cervi Degelatinatum 3% Os Draconis 5%
Rhizoma Drynariae 5% Herba Epimedii 2% Rhizoma Cibotii 3% Cortex Eucommiae 3%
XUESANQI 4% tap 7 4% is kowtowed son 7 4% Radix Caulophyllis 4%
Herba Parnassiae Wightianae 2% Rhizoma Atractylodis 5% Radix Angelicae Dahuricae 3% Herba Asari 3%
Millettia Speciosa 3% Radix Flemingiae Philippinensis 4% Rhizoma Et Radix Notopterygii 4% Radix Angelicae Pubescentis 2%
Radix Aconiti 3% Radix Aconiti Kusnezoffii 3.5% eupolyphoge sinensis 2% Scolopendra 2%
Herba Ephedrae 2%
By traditional method, refine into cream, spread out on cardboard, topped thereon layer of transparent plastic sheeting is goods.
Embodiment 2:
Radix Angelicae Sinensis 4% Flos Carthami 1.5% Semen Persicae 1.5% Rhizoma Chuanxiong 1%
Caulis seu Radix Schisandrae Henryi 1.5% breast does not have 2% Radix Notoginseng, 1% Radix Rehmanniae Preparata 3%
Herba Cistanches 3% Fructus Psoraleae 3% Cornu Cervi Degelatinatum 4% Os Draconis 4%
Rhizoma Drynariae 4% Herba Epimedii 3% Rhizoma Cibotii 3% Cortex Eucommiae 3%
XUESANQI 5% tap 7 5% is kowtowed son 7 5% Radix Caulophyllis 4%
Herba Parnassiae Wightianae 2% Rhizoma Atractylodis 4% Radix Angelicae Dahuricae 2% Herba Asari 3%
Millettia Speciosa 3.5% Radix Flemingiae Philippinensis 3% Rhizoma Et Radix Notopterygii 3% Radix Angelicae Pubescentis 3%
Radix Aconiti 3% Radix Aconiti Kusnezoffii 5% eupolyphoge sinensis 2% Scolopendra 2%
Herba Ephedrae 3%
By traditional method, refine into cream, spread out on cardboard, topped thereon layer of transparent plastic sheeting is goods.

Claims (2)

1. a plaster for the treatment of rheumatic spur is characterized in that, it is made by the following weight proportion raw material:
Radix Angelicae Sinensis 0.9-4.9% Flos Carthami 0.9-1.7% Semen Persicae 0.9-1.7%
Rhizoma Chuanxiong 0.9-1.7% Caulis seu Radix Schisandrae Henryi 0.9-1.7% breast does not have 0.9-5.2%
Radix Notoginseng 0.9-5.2% Radix Rehmanniae Preparata 2.6-5.2% Herba Cistanches 2.6-5.2%
Fructus Psoraleae 2.6-5.2% Cornu Cervi Degelatinatum 2.6-5.2% Os Draconis 2.6-5.2%
Rhizoma Drynariae 2.6-5.2% Herba Epimedii 1.7-3.5% Rhizoma Cibotii 1.7-5.2%
Cortex Eucommiae 1.7-5.2% XUESANQI 1.7-5.2% tap seven 1.7-5.2%
Kowtow sub seven 1.7-5.2% Radix Caulophylli 1.7-5.2% Herba Parnassiae Wightianae 1.7-2%
Rhizoma Atractylodis 1.7-5.2% Radix Angelicae Dahuricae 1.7-3.5% Herba Asari 1.7-3.5%
Millettia Speciosa 1.7-5.2% Radix Flemingiae Philippinensis 1.7-5.2% Rhizoma Et Radix Notopterygii 1.7-5.2%
Radix Angelicae Pubescentis 1.7-5.2% Radix Aconiti 1.7-5.2% Radix Aconiti Kusnezoffii 1.7-5.2%
Eupolyphoge sinensis 1.7-3.5% Scolopendra 1.7-3.5% Herba Ephedrae 1.7-5.2%
2. the plaster of treatment rheumatic spur according to claim 1, wherein the weight proportion of each raw material is:
Radix Angelicae Sinensis 1-4% Flos Carthami 1-1.5% Semen Persicae 1-1.5%
Rhizoma Chuanxiong 1-1.5% Caulis seu Radix Schisandrae Henryi 1-1.5% breast does not have 1-5%
Radix Notoginseng 1-5% Radix Rehmanniae Preparata 3-5% Herba Cistanches 3-5%
Fructus Psoraleae 3-5% Cornu Cervi Degelatinatum 3-5% Os Draconis 3-5%
Rhizoma Drynariae 3-5% Herba Epimedii 2-3% Rhizoma Cibotii 2-5%
Cortex Eucommiae 2-5% XUESANQI 2-5% tap seven 2-5%
Kowtow sub seven 2-5% Radix Caulophylli 2-5% Herba Parnassiae Wightianae 1.7-2%
Rhizoma Atractylodis 2-5% Radix Angelicae Dahuricae 2-3% Herba Asari 2-3%
Millettia Speciosa 2-5% Radix Flemingiae Philippinensis 2-5% Rhizoma Et Radix Notopterygii 2-5%
Radix Angelicae Pubescentis 2-5% Radix Aconiti 2-5% Radix Aconiti Kusnezoffii 2-5%
Eupolyphoge sinensis 2-3% Scolopendra 2-3% Herba Ephedrae 2-5%
CN99116404A 1999-03-29 1999-03-29 Ointment for rheumatic spur Expired - Fee Related CN1086298C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN99116404A CN1086298C (en) 1999-03-29 1999-03-29 Ointment for rheumatic spur

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN99116404A CN1086298C (en) 1999-03-29 1999-03-29 Ointment for rheumatic spur

Publications (2)

Publication Number Publication Date
CN1231203A CN1231203A (en) 1999-10-13
CN1086298C true CN1086298C (en) 2002-06-19

Family

ID=5279225

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99116404A Expired - Fee Related CN1086298C (en) 1999-03-29 1999-03-29 Ointment for rheumatic spur

Country Status (1)

Country Link
CN (1) CN1086298C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102018792B (en) * 2010-11-19 2012-09-12 王丽华 Traditional Chinese medicine for treating ankylosing spondylitis
CN104491146A (en) * 2014-12-18 2015-04-08 青岛百瑞吉生物工程有限公司 Traditional Chinese ointment for treating hyperostosis as well as preparation method and application of traditional Chinese ointment

Also Published As

Publication number Publication date
CN1231203A (en) 1999-10-13

Similar Documents

Publication Publication Date Title
CN1118285C (en) Shubi plaster for treating arthralgia due to wind-cold-dampness
CN1706441A (en) Arthralgia treating plaster
CN1857541A (en) Plaster for treating rheumatism and osteoarthrosis
CN1803187A (en) Chinese herbal medicine for treating lumbar intervertebral disk protrusion and hyperosteogeny
CN1586547A (en) Medicine for treating bone wound
CN1091609C (en) Tincture for treating rheumatoid arthritis and its preparing process
CN101450197B (en) Traditional Chinese medicine for treating rheumatism, rheumatoid disease
CN102247497A (en) Chinese patent medicine for treating rheumatoid arthritis
CN1429616A (en) New preparation of compound Chinese medicine for treating osteoarthritis and its preparation method
CN106266939A (en) A kind of Chinese medicine composition, the transdermal patch for neck waist rehabilitation comprising this Chinese medicine composition and preparation and application
CN107375845A (en) External composition for dispelling wind, eliminating dampness, clearing and activating channels and collaterals and use method thereof
CN103800489A (en) Traditional Chinese medicine wine for treating cervical spondylosis and preparation method of traditional Chinese medicine wine
CN106177819A (en) A kind of external medicine composition for cervical spondylosis, preparation method and applications
CN103041108B (en) Medicinal liquor and preparation method thereof
CN1086298C (en) Ointment for rheumatic spur
CN1247086A (en) Process for making medical wine for treating rheumatism
CN1840164A (en) Plaster for treating spur caused by wind-coldness
CN1772245A (en) Snake medicinal wine for health care massage and its application
CN1261131C (en) Medicinal plaster for treating cervical vertebra disease
CN1063338C (en) Traditional Chinese medicine preparation for curing cervical and lumbar hyperosteogeny
CN105688059A (en) Traditional Chinese medicine preparation with folium artemisiae argyi for treating osteoproliferation through external application
CN105232942A (en) Traditional Chinese medicine compound treating generalized dystonia
CN1200724C (en) Pill for activating collateral flow and removing spur
CN105311559A (en) Medicinal liquor for treating scapulohumeral periarthritis
CN1286105A (en) Moxiburning medicine for acupoint therapy

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee